Apatinib for Advanced Biliary Carcinoma

Clinical trial NCT03427242 · UNKNOWN

Trial details

NCT number: NCT03427242
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Neoplasms

Start date: 2017-11-01
Primary completion: 2021-10-31
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.